IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients (2017)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s41241-017-0017-9
- Subjects: LEUCEMIA MIELOIDE; IMUNOLOGIA; INTERLEUCINAS; CITOCINAS
- Keywords: IL-32; Myelodysplastic syndromes; Disease progression; CD3+ cells; Immunology
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Applied Cancer Research
- ISSN: 1980-5578
- Volume/Número/Paginação/Ano: v. 37, art. 9, 6 p., 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LOPES, Matheus Rodrigues et al. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, v. 37, p. 6 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s41241-017-0017-9. Acesso em: 24 jan. 2026. -
APA
Lopes, M. R., Pereira, J. K. N., Traina, F., Campos, P. de M., Machado Neto, J. A., Saad, S. T. O., & Favaro, P. (2017). IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, 37, 6 . doi:10.1186/s41241-017-0017-9 -
NLM
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2026 jan. 24 ] Available from: https://doi.org/10.1186/s41241-017-0017-9 -
Vancouver
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2026 jan. 24 ] Available from: https://doi.org/10.1186/s41241-017-0017-9 - Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome
- STMN1 (stathmin 1)
- Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
- Differential profile of PIP4K2A expression in hematological malignancies
- FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
- Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression
Informações sobre o DOI: 10.1186/s41241-017-0017-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
